The present invention is concerned with novel spiro-piperidine derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful in the prevention and/or treatment of anxiety and depressive disorders and other diseases.
In particular, the present invention is concerned with compounds of the general formula (I)
wherein R
1
to R
5
, R
5′
, X, Y and A are as defined in the specification.
本发明涉及新型螺环
哌啶衍
生物作为V1a受体拮抗剂,它们的制造、包含它们的药物组合物以及它们作为药物的用途。本发明的活性化合物在预防和/或治疗焦虑和抑郁症等疾病方面具有用处。特别是,本发明涉及一般式(I)中R1至R5,R5',X,Y和A所定义的化合物。